N🟁N

Tourism leads the pack in growing carbon emissions

The article from ScienceDaily discusses a study published in the journal *Nature Communications* that explores the potential of using a common cold virus, specifically a modified strain of the Coxsackievirus B3 (CVB3), as a treatment for cancer. Researchers found that this virus can selectively target and kill cancer cells while leaving healthy cells unharmed. The study highlights how the virus was genetically modified to enhance its cancer-killing properties without causing significant side effects. Experiments showed promising results in both cell cultures and animal models, where the virus not only reduced tumor size but also stimulated an immune response against cancer cells. This approach could potentially lead to new, less invasive cancer therapies, although further research is needed to ensure safety and efficacy in human trials.

Read the Full Science Daily Article at:
[ https://www.sciencedaily.com/releases/2024/12/241210114957.htm ]